ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oligonucleotide Therapeutics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-26O10944
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oligonucleotide Therapeutics Sales Market Report 2022
BUY CHAPTERS

Global Oligonucleotide Therapeutics Market Research Report 2024

Code: QYRE-Auto-26O10944
Report
January 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics

Oligonucleotide Therapeutics Market Size

The global Oligonucleotide Therapeutics market was valued at US$ 3678.1 million in 2023 and is anticipated to reach US$ 10970 million by 2030, witnessing a CAGR of 16.7% during the forecast period 2024-2030.

Oligonucleotide Therapeutics Market

Oligonucleotide Therapeutics Market

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.
Biogen is the industry's biggest player, with more than 76 percent of 2018 revenue, followed by Sarepta Therapeutics and Jazz Pharmaceuticals, with 13.35 percent and 6.63 percent, respectively. North America and Europe are the most important regions, accounting for more than 80 percent of the combined income.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Therapeutics.

Report Scope

The Oligonucleotide Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oligonucleotide Therapeutics Market Report

Report Metric Details
Report Name Oligonucleotide Therapeutics Market
Accounted market size in 2023 US$ 3678.1 million
Forecasted market size in 2030 US$ 10970 million
CAGR 16.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Antisense Oligonucleotide
  • Aptamer
  • Other
Segment by Application
  • Neuromuscular Diseases
  • ATTR
  • Hepatic VOD
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics, Akcea Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oligonucleotide Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oligonucleotide Therapeutics Market growing?

Ans: The Oligonucleotide Therapeutics Market witnessing a CAGR of 16.7% during the forecast period 2024-2030.

What is the Oligonucleotide Therapeutics Market size in 2030?

Ans: The Oligonucleotide Therapeutics Market size in 2030 will be US$ 10970 million.

Who are the main players in the Oligonucleotide Therapeutics Market report?

Ans: The main players in the Oligonucleotide Therapeutics Market are Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics, Akcea Therapeutics

What are the Application segmentation covered in the Oligonucleotide Therapeutics Market report?

Ans: The Applications covered in the Oligonucleotide Therapeutics Market report are Neuromuscular Diseases, ATTR, Hepatic VOD, Other

What are the Type segmentation covered in the Oligonucleotide Therapeutics Market report?

Ans: The Types covered in the Oligonucleotide Therapeutics Market report are Antisense Oligonucleotide, Aptamer, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antisense Oligonucleotide
1.2.3 Aptamer
1.2.4 Other
1.3 Market by Application
1.3.1 Global Oligonucleotide Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Neuromuscular Diseases
1.3.3 ATTR
1.3.4 Hepatic VOD
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Therapeutics Market Perspective (2019-2030)
2.2 Oligonucleotide Therapeutics Growth Trends by Region
2.2.1 Global Oligonucleotide Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oligonucleotide Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Oligonucleotide Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Oligonucleotide Therapeutics Market Dynamics
2.3.1 Oligonucleotide Therapeutics Industry Trends
2.3.2 Oligonucleotide Therapeutics Market Drivers
2.3.3 Oligonucleotide Therapeutics Market Challenges
2.3.4 Oligonucleotide Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Therapeutics Players by Revenue
3.1.1 Global Top Oligonucleotide Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Oligonucleotide Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Oligonucleotide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oligonucleotide Therapeutics Revenue
3.4 Global Oligonucleotide Therapeutics Market Concentration Ratio
3.4.1 Global Oligonucleotide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Therapeutics Revenue in 2023
3.5 Oligonucleotide Therapeutics Key Players Head office and Area Served
3.6 Key Players Oligonucleotide Therapeutics Product Solution and Service
3.7 Date of Enter into Oligonucleotide Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Therapeutics Breakdown Data by Type
4.1 Global Oligonucleotide Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Oligonucleotide Therapeutics Forecasted Market Size by Type (2025-2030)
5 Oligonucleotide Therapeutics Breakdown Data by Application
5.1 Global Oligonucleotide Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Oligonucleotide Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oligonucleotide Therapeutics Market Size (2019-2030)
6.2 North America Oligonucleotide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oligonucleotide Therapeutics Market Size by Country (2019-2024)
6.4 North America Oligonucleotide Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide Therapeutics Market Size (2019-2030)
7.2 Europe Oligonucleotide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oligonucleotide Therapeutics Market Size by Country (2019-2024)
7.4 Europe Oligonucleotide Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Oligonucleotide Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oligonucleotide Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Oligonucleotide Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligonucleotide Therapeutics Market Size (2019-2030)
9.2 Latin America Oligonucleotide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oligonucleotide Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Oligonucleotide Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Oligonucleotide Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oligonucleotide Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Oligonucleotide Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Oligonucleotide Therapeutics Introduction
11.1.4 Biogen Revenue in Oligonucleotide Therapeutics Business (2019-2024)
11.1.5 Biogen Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Detail
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Introduction
11.2.4 Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2019-2024)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Detail
11.3.2 Jazz Pharmaceuticals Business Overview
11.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Introduction
11.3.4 Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2019-2024)
11.3.5 Jazz Pharmaceuticals Recent Development
11.4 Bausch & Lomb
11.4.1 Bausch & Lomb Company Detail
11.4.2 Bausch & Lomb Business Overview
11.4.3 Bausch & Lomb Oligonucleotide Therapeutics Introduction
11.4.4 Bausch & Lomb Revenue in Oligonucleotide Therapeutics Business (2019-2024)
11.4.5 Bausch & Lomb Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2019-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Dynavax Technologies
11.6.1 Dynavax Technologies Company Detail
11.6.2 Dynavax Technologies Business Overview
11.6.3 Dynavax Technologies Oligonucleotide Therapeutics Introduction
11.6.4 Dynavax Technologies Revenue in Oligonucleotide Therapeutics Business (2019-2024)
11.6.5 Dynavax Technologies Recent Development
11.7 Kastle therapeutics
11.7.1 Kastle therapeutics Company Detail
11.7.2 Kastle therapeutics Business Overview
11.7.3 Kastle therapeutics Oligonucleotide Therapeutics Introduction
11.7.4 Kastle therapeutics Revenue in Oligonucleotide Therapeutics Business (2019-2024)
11.7.5 Kastle therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Introduction
11.8.4 Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Business (2019-2024)
11.8.5 Akcea Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics
List of Tables
    Table 1. Global Oligonucleotide Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Antisense Oligonucleotide
    Table 3. Key Players of Aptamer
    Table 4. Key Players of Other
    Table 5. Global Oligonucleotide Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Oligonucleotide Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Oligonucleotide Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Oligonucleotide Therapeutics Market Share by Region (2019-2024)
    Table 9. Global Oligonucleotide Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Oligonucleotide Therapeutics Market Share by Region (2025-2030)
    Table 11. Oligonucleotide Therapeutics Market Trends
    Table 12. Oligonucleotide Therapeutics Market Drivers
    Table 13. Oligonucleotide Therapeutics Market Challenges
    Table 14. Oligonucleotide Therapeutics Market Restraints
    Table 15. Global Oligonucleotide Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Oligonucleotide Therapeutics Market Share by Players (2019-2024)
    Table 17. Global Top Oligonucleotide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics as of 2023)
    Table 18. Ranking of Global Top Oligonucleotide Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Oligonucleotide Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Oligonucleotide Therapeutics Product Solution and Service
    Table 22. Date of Enter into Oligonucleotide Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Oligonucleotide Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Oligonucleotide Therapeutics Revenue Market Share by Type (2019-2024)
    Table 26. Global Oligonucleotide Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Oligonucleotide Therapeutics Revenue Market Share by Type (2025-2030)
    Table 28. Global Oligonucleotide Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Oligonucleotide Therapeutics Revenue Market Share by Application (2019-2024)
    Table 30. Global Oligonucleotide Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Oligonucleotide Therapeutics Revenue Market Share by Application (2025-2030)
    Table 32. North America Oligonucleotide Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Oligonucleotide Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Oligonucleotide Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Oligonucleotide Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Oligonucleotide Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Oligonucleotide Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Oligonucleotide Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Oligonucleotide Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Oligonucleotide Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Oligonucleotide Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Oligonucleotide Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Oligonucleotide Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Oligonucleotide Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Oligonucleotide Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Oligonucleotide Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Biogen Company Detail
    Table 48. Biogen Business Overview
    Table 49. Biogen Oligonucleotide Therapeutics Product
    Table 50. Biogen Revenue in Oligonucleotide Therapeutics Business (2019-2024) & (US$ Million)
    Table 51. Biogen Recent Development
    Table 52. Sarepta Therapeutics Company Detail
    Table 53. Sarepta Therapeutics Business Overview
    Table 54. Sarepta Therapeutics Oligonucleotide Therapeutics Product
    Table 55. Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2019-2024) & (US$ Million)
    Table 56. Sarepta Therapeutics Recent Development
    Table 57. Jazz Pharmaceuticals Company Detail
    Table 58. Jazz Pharmaceuticals Business Overview
    Table 59. Jazz Pharmaceuticals Oligonucleotide Therapeutics Product
    Table 60. Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2019-2024) & (US$ Million)
    Table 61. Jazz Pharmaceuticals Recent Development
    Table 62. Bausch & Lomb Company Detail
    Table 63. Bausch & Lomb Business Overview
    Table 64. Bausch & Lomb Oligonucleotide Therapeutics Product
    Table 65. Bausch & Lomb Revenue in Oligonucleotide Therapeutics Business (2019-2024) & (US$ Million)
    Table 66. Bausch & Lomb Recent Development
    Table 67. Alnylam Pharmaceuticals Company Detail
    Table 68. Alnylam Pharmaceuticals Business Overview
    Table 69. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Product
    Table 70. Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2019-2024) & (US$ Million)
    Table 71. Alnylam Pharmaceuticals Recent Development
    Table 72. Dynavax Technologies Company Detail
    Table 73. Dynavax Technologies Business Overview
    Table 74. Dynavax Technologies Oligonucleotide Therapeutics Product
    Table 75. Dynavax Technologies Revenue in Oligonucleotide Therapeutics Business (2019-2024) & (US$ Million)
    Table 76. Dynavax Technologies Recent Development
    Table 77. Kastle therapeutics Company Detail
    Table 78. Kastle therapeutics Business Overview
    Table 79. Kastle therapeutics Oligonucleotide Therapeutics Product
    Table 80. Kastle therapeutics Revenue in Oligonucleotide Therapeutics Business (2019-2024) & (US$ Million)
    Table 81. Kastle therapeutics Recent Development
    Table 82. Akcea Therapeutics Company Detail
    Table 83. Akcea Therapeutics Business Overview
    Table 84. Akcea Therapeutics Oligonucleotide Therapeutics Product
    Table 85. Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Business (2019-2024) & (US$ Million)
    Table 86. Akcea Therapeutics Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oligonucleotide Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Oligonucleotide Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Antisense Oligonucleotide Features
    Figure 4. Aptamer Features
    Figure 5. Other Features
    Figure 6. Global Oligonucleotide Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Oligonucleotide Therapeutics Market Share by Application: 2023 VS 2030
    Figure 8. Neuromuscular Diseases Case Studies
    Figure 9. ATTR Case Studies
    Figure 10. Hepatic VOD Case Studies
    Figure 11. Other Case Studies
    Figure 12. Oligonucleotide Therapeutics Report Years Considered
    Figure 13. Global Oligonucleotide Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Oligonucleotide Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Oligonucleotide Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Oligonucleotide Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Oligonucleotide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Oligonucleotide Therapeutics Revenue in 2023
    Figure 19. North America Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Oligonucleotide Therapeutics Market Share by Country (2019-2030)
    Figure 21. United States Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Oligonucleotide Therapeutics Market Share by Country (2019-2030)
    Figure 25. Germany Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Oligonucleotide Therapeutics Market Share by Region (2019-2030)
    Figure 33. China Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Oligonucleotide Therapeutics Market Share by Country (2019-2030)
    Figure 41. Mexico Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Oligonucleotide Therapeutics Market Share by Country (2019-2030)
    Figure 45. Turkey Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Oligonucleotide Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Biogen Revenue Growth Rate in Oligonucleotide Therapeutics Business (2019-2024)
    Figure 48. Sarepta Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2019-2024)
    Figure 49. Jazz Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Business (2019-2024)
    Figure 50. Bausch & Lomb Revenue Growth Rate in Oligonucleotide Therapeutics Business (2019-2024)
    Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Business (2019-2024)
    Figure 52. Dynavax Technologies Revenue Growth Rate in Oligonucleotide Therapeutics Business (2019-2024)
    Figure 53. Kastle therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2019-2024)
    Figure 54. Akcea Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2019-2024)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Aptamer Based Quartz Crystal Microbalance Sensor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-28A12969
Wed May 08 00:00:00 UTC 2024

Add to Cart

Global Nesiritide Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14P12309
Wed May 08 00:00:00 UTC 2024

Add to Cart

Global Cell Free DNA Isolation Kit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4A12467
Wed May 08 00:00:00 UTC 2024

Add to Cart

Global Septic Shock Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39I13147
Wed May 08 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions